Literature DB >> 11348020

Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.

J P Sikora1, D Chlebna-Sokół, I Dabrowska, D Lipczyński, S Chrul.   

Abstract

This study was to evaluate the levels of the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) and the cytokine inhibitors soluble TNF-alpha receptor (sTNFR) and interleukin (IL-1) receptor antagonist (IL-1ra), as well as the intensity of oxidative metabolism of peripheral blood polymorphonuclear leukocytes in the course of sepsis in newborns. An increase of TNF-alpha, sTNFR and IL-1ra concentrations was found in the blood serum of the patients at the time of diagnosis. This was further accompanied by polymorphonuclear leukocyte stimulation and, as a consequence of prolonged bacterial antigen stimulation, functional exhaustion of these cells and their diminished oxidative metabolism was observed. Within the same time period, an enhanced expression of p55 and p75 TNF-alpha receptors on polymorphonuclear leukocyte cell surfaces was found. It was indicated that the applied pharmacotherapy caused a decrease of the initially elevated concentrations of TNF-alpha and proinflammatory cytokine inhibitors (sTNFR, IL-1ra). The intensive therapy of sepsis was associated with the increased oxidative burst of polymorphonuclear leukocytes along with the decrease of p55 and p75 expression on their cell surfaces.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348020

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  2 in total

1.  Comparison of the clinical application of reactive oxygen species and inflammatory markers in patients with endocarditis.

Authors:  Stanisław Ostrowski; Anna Marcinkiewicz; Dariusz Nowak; Radosław Zwoliński; Ryszard Jaszewski
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

2.  The tripeptide feG inhibits leukocyte adhesion.

Authors:  Ronald D Mathison; Emily Christie; Joseph S Davison
Journal:  J Inflamm (Lond)       Date:  2008-05-20       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.